Prescription Drug Dangers
Click on any drug for additional information
Abilify (aripiprazole)
- Total adverse event reports: 16,904
- Average age: 39 years
- Reported Deaths: 281
- Male: 37%
- Female: 50%
- Gender Unknown: 13%
- Difficulty with speaking
- Confusion
- EPS (drooling, loss of balance control, muscle trembling, jerking, or stiffness, restlessness, shuffling walk, stiffness of the limbs, twisting movements of the body, uncontrolled movements, especially of the face, neck, and back)
- Long-term effects such as metabolic syndrome (disordered use and storage of energy, resulting in obesity, high blood pressure and serum glucose levels, increasing the risk of cardiovascular disease and diabetes) are of greatest concern
- Increased risk of developing Type II diabetes (even if you don’t gain weight due to elevated lipid, cholesterol, and blood sugar levels)
- This drug can also lower your seizure threshold
Most common adverse effects reported to FDA:
- Weight gain
- Tardive dyskinesia (involuntary movements of face, jaw)
- Tremor
- Insomnia
- Akathisia (agitation, distress)
- Dyskinesia (abnormal or impaired voluntary movement)
- Drug ineffectiveness
- Nausea
- Psychotic disorder
- Sleepiness
You should avoid this drug if:
- You are elderly, have dementia (such as Alzheimer’s disease), have any history of cardiovascular (heart) disease, diabetes, or have seizures
- Pediatric patients should not use this drug for the treatment of depression
Like Seroquel and Zyprexa, Abilify is used to treat psychotic symptoms in conditions such as schizophrenia, bipolar disorders, psychotic disorders, as well as major depressive disorder in adults. It is also used to treat the irritability and severe mood symptoms (aggression, self-injury) in autism.
Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Although the causes of death were varied in clinical trials, most of the deaths appeared to be either cardiovascular (heart failure, sudden death) or infectious (pneumonia) in nature. Abilify is not approved for the treatment of patients with dementia-related psychosis. Antidepressants have been shown to increase the risk of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults compared to placebo drugs in short-term studies of major depressive disorder and other psychiatric disorders. Anyone considering the use of Abilify as an adjunctive therapy or considering the use of any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Abilify is not approved for use in pediatric patients with depression.
Adderall (amphetamine and dextroamphetamine)
- Total adverse event reports: 3,052
- Average age: 28 years
- Reported Deaths: 178
- Male: 49%
- Female: 42%
- Gender Unknown: 9%
- Loss of appetite
- Weight loss
- Dry mouth
- Gastrointestinal upset (pain, nausea, vomiting)
- Dizziness
- Headache
- Diarrhea
- Nervousness
- Mood changes (agitation, anxiety, depression, aggression, mood swings)
- Trouble sleeping
- Hair loss
- Addiction (amphetamine and dextroamphetamine are habit forming)
Most common adverse effects reported to FDA:
- Drug ineffectiveness
- Headache
- Insomnia
- Aggression
- Completed suicide
- Overdose
- Anxiety
- Depression
- Fatigue
- Agitation
You should avoid this drug if:
- You are pregnant or breastfeeding. These drugs can pass into breast milk and may harm a nursing baby.
- Pediatric patients should not use this drug for the treatment of depression.
Adderall is used to treat narcolepsy and attention deficit hyperactivity disorder (ADHD). Adderall contains CNS stimulants that affect chemicals in the brain and nerves that contribute to hyperactivity and impulse control.
An advisory panel to the FDA recently recommended that Adderall and other drugs (such as Ritalin, Concerta) used to treat ADHD should display a black box warning because amphetamines are known to raise blood pressure (causing chest pain, irregular heartbeat, fainting) leading to stroke and heart attack. While Canada ordered Adderall off the market, the FDA only required a warning be added to the packaging advising people with structural heart abnormalities not to use the drug.
Avastin (bevacizumab)
- Total adverse event reports: 20,963
- Average age: 61 years
- Reported Deaths: 1786
- Male: 44%
- Female: 47%
- Gender Unknown: 2%
- Generalized weakness
- Abdominal pain
- Gastrointestinal distress (nausea, vomiting)
- Appetite disturbances, constipation
- Infection (especially upper respiratory) due to low white blood cell count
- Kidney problems
- Bleeding problems (nose bleeds, etc.)
- Hair loss
- Headache
- Dizziness
- Weight loss
Most common adverse effects reported to FDA:
- Death
- Disease progression
- Abdominal upset (diarrhea, nausea, vomiting, pain)
- Dehydration
- High blood pressure
- Fever
- Difficulty breathing
- Fatigue
You should avoid this drug if:
- You are pregnant or planning to become pregnant in the near future as it may cause damage to your unborn baby
- You will need to use contraception during treatment and for at least 6 months after your last dose of this drug
- Be aware that Avastin may interfere with your ability to become pregnant in the future; your doctor should advise you of your options prior to starting treatment
- You should not breast-feed while being treated with this drug and for at least 6 months after the last dose as Avastin may interfere with the growth and development of your baby
Used for treatment of various cancers as part of a combination chemotherapy regimen.
Complications in healing from surgery and other wounds have been reported. Hemorrhage is also more frequent in patients receiving this drug that can lead to death.
Celebrex (celecoxib)
- Total adverse event reports: 27,018
- Average age: 61 years
- Reported Deaths: 496
- Male: 37%
- Female: 56%
- Gender Unknown: 7%
- Life-threatening heart or circulation problems such as heart attack or stroke (especially if used long term)
- Serious effects on stomach or intestines (bleeding or perforation)
Most common adverse effects reported to FDA:
- Death
- Heart attack
- Stroke
- Drug ineffectiveness
- Pain
- High blood pressure
- Difficulty breathing
- Joint pain
- Rash
- Depression
- Chest pain
You should avoid this drug if:
- FDA pregnancy category D. Taking Celebrex during the last 3 months of pregnancy may harm the unborn baby.
- Tell your doctor if you are pregnant or plan to become pregnant while using Celebrex. Celecoxib
passes into breast milk and may affect a nursing baby. Do not take Celebrex without first talking to your doctor if you are breast-feeding a baby. Do not give this medicine to a child younger than 2 years old without the advice of a doctor. - Avoid too much sunlight or tanning beds. Celebrex can make you sunburn more easily.
- Fatal reactions can occur without warning while taking Celebrex especially in older adults.
Used to treat pain or inflammation caused by many conditions such as arthritis, ankylosing spondylitis, and menstrual pain. It is also used in the treatment of hereditary polyps in the colon.
NSAIDS may increase the risk of serious and potentially fatal cardiac events. Stroke risk may also increase with prolonged use. These drugs may also increase the risk of serious adverse gastrointestinal events, including ulcers, abdominal or intestinal perforation, which can be fatal, especially in elderly patients.
Crestor (ROSUVASTATIN)
- Total adverse event reports: 31,463
- Average age: 64 years
- Reported Deaths: 238
- Male: 40%
- Female: 55%
- Gender Unknown: 5%
- Myopathy (muscle pain)
- Kidney damage
- Liver damage
- Type 2 diabetes
- Memory loss
- Muscle pain
- Rhabdomyolysis (breakdown of muscle fiber) leading to kidney failure and death
- Side effects such as liver toxicity and muscle inflammation
Most common adverse effects reported to FDA:
- Muscle pain, pain in extremities, and muscle spasms
- Muscle cell damage (Rhabdomyolysis)
- Malaise
- Fatigue
- Joint pain
- Headache
- Muscular weakness
You should avoid this drug if:
- Women who are pregnant or nursing should not take this drug. Crestor may cause harm to unborn child when administered to pregnant women.
- This and other drugs in this class pass into breast milk and have the potential to cause serious adverse reactions in nursing infants. Women who require this drug should not nurse their infants.
Used to treat high cholesterol
The FDA has rejected calls by consumer advocates for a new black box warning for Crestor and other statin-based medications that would ensure that information about the risk of severe and potentially life-threatening muscle problems and kidney damage is placed more prominently on these drug labels.
Cymbalta (DULOXETINE)
- Total adverse event reports: 24,595
- Average age: 51 years
- Reported Deaths: 742
- Male: 27%
- Female: 71%
- Gender Unknown: 2%
- Liver problems
- Hepatitis
- Jaundice resulting from abnormal bile flow
- Symptoms of liver damage: jaundice, dark urine, weakness, nausea, abdominal tenderness near the liver, flu like symptoms
Most common adverse effects reported to FDA:
- Nausea
- Dizziness
- Headache
- Insomnia
- Fatigue
- Depression
- Drug withdrawal syndrome
- Drug ineffectiveness
- Anxiety
- Liver damage
You should avoid this drug if:
- Women who are pregnant or nursing should not take this drug. Duloxetine can pass into breast milk and may harm a nursing baby.
Used to treat major depression, anxiety, fibromyalgia, joint pain, diabetic neuropathy
Cymbalta and other antidepressants have been shown to increase the risk of suicidality in children, adolescents, and young adults with major depressive or other psychiatric disorders.
DEPAKOTE (VALPROIC ACID)
- Total adverse event reports: 11,678
- Average age: 39 years
- Reported Deaths: 168
- Male: 41%
- Female: 45%
- Gender Unknown: 14%
- Myopathy (muscle pain)
- Digestive complaints (diarrhea, nausea, vomiting, indigestion)
- Vision problems (seeing double or lazy eye)
- Hormonal disturbances
- Weight gain
- Hair loss
- Memory problems
- Bleeding
- Tinnitus
- Dizziness
- Drowsiness
- Tremor
- Headache
Most common adverse effects reported to FDA:
- Muscle pain, pain in extremities, and muscle spasms
- Convulsions
- Interactions with other drugs
- Suicide
- Tremor
- Sleepiness
- Drug ineffectiveness
- Weight gain
- Vomiting
- Confusion
- Hair loss
You should avoid this drug if:
- This drug should be avoided during pregnancy. Depakote can harm an unborn baby or cause birth defects, and may affect cognition (intelligence, problem-solving, reasoning abilities) later in the child’s life.
- If you already take Depakote for seizures or manic episodes: Do not start or stop taking this medicine during pregnancy without your doctor’s advice. While Depakote can cause harm to an unborn baby, having a seizure during pregnancy could harm both the mother and the baby. Contact your doctor right away.
- This drug can pass into breast milk and may harm a nursing baby.
- You should not use Depakote if you have liver disease, a urea cycle disorder, or certain genetic disorders (such as Alpers’ disease or Alpers-Huttenlocher syndrome)
- Children under 2 should not take this drug if mitochondrial disorders are present as Depakote can cause fatal liver failure
Used primarily in the treatment of epilepsy (seizure disorder), bipolar disorder, and the prevention of migraine headache
Valproate causes birth defects; exposure during pregnancy is associated with about three times as many major anomalies as usual, including and several other defects, possibly including a “valproate syndrome.” Cases of life threatening pancreatitis have also been reported in both children and adults receiving this drug. Some of the cases have been described as hemorrhagic with rapid progression from initial use as well as after several years of use. Patients and guardians should be warned that abdominal pain, nausea, vomiting, and/or anorexia can be symptoms of pancreatitis that require prompt medical evaluation.
ENBREL (ENTANERCEPT)
- Total adverse event reports: 11,678
- Average age: 39 years
- Reported Deaths: 168
- Male: 41%
- Female: 45%
- Gender Unknown: 14%
- Pain
- Bruising
- Burning at injection site
- Respiratory and other infections
- Fatigue, gastrointestinal distress
- Headaches
- Enbrel can increase the risk of developing lymphoma (a type of cancer involving cells of the immune system
- Some patients using Enbrel have developed: Lymphomas affecting the liver, spleen, and bone marrow that have been fatal (This condition has occurred mainly in teenagers and young adults)
Most common adverse effects reported to FDA:
- Injection site pain, irritation, swelling, and other reactions including hematoma
- Psoriasis
- Rheumatoid arthritis and joint pain
- Drug ineffectiveness
- Headache
You should avoid this drug if:
- You are pregnant, planning on becoming pregnant in the near future, or are currently breast feeding
- You have cancer or have had a past history of certain cancers
- You have severe or uncontrolled congestive heart failure
- You have multiple sclerosis
- You have active infections, such as tuberculosis
Enbrel is used to treat the symptoms of rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis, and to prevent joint damage caused by these conditions. Also used to treat plaque psoriasis in adults and polyarticular juvenile idiopathic arthritis in children who are at least 2 years old.
Serious infection risk associated with Enbrel. Benefits vs risk in patients with chronic or recurrent infection must be weighed. Tuberculosis (TB) is a risk, as are invasive fungal and other opportunistic infections; some of these infections have been fatal. Cancers such as lymphoma and other malignancies, some fatal, have been reported in children and adolescents treated with TNF blockers like Enbrel and Humira.
Humira (ADALIMUMAB)
- Total adverse event reports: 127,413
- Average age: 51 years
- Reported Deaths: 970
- Male: 29%
- Female: 68%
- Gender Unknown: 3%
- Serious infections
- Tuberculosis (TB) and infections caused by viruses, fungi, or bacteria, have occurred in patients taking this drug
- Humira may increase the chance of getting lymphoma or other cancers
- Hepatitis B in carriers of the virus is also a potential side effect
- Allergic reactions
- Nervous system problems
- Fever that does not go away
- Bruising or bleeding very easily
- Heart failure (new or worsening)
- Shortness of breath
- Swelling of your ankles or feet
- Sudden weight gain
- Immune system reactions may include a lupus-like syndrome
- Liver problems or psoriasis (new or worsening) may also occur
Most common adverse effects reported to FDA:
- Injection site pain
- Drug ineffectiveness
- Joint pain
- Pain
- Fatigue
- Headache
- Stomach upset (including nausea, diarrhea)
You should avoid this drug if:
- You are pregnant, planning on becoming pregnant in the near future, or are currently breast feeding
- You have cancer or have had a past history of certain cancers
- You have severe or uncontrolled congestive heart failure
- You have multiple sclerosis
- You have active infections, such as tuberculosis
Used to treat rheumatoid arthritis, plaque psoriasis, Chrone’s disease, ulcerative colitis, psoriatic arthritis, juvenile idiopathic arthritis
Patients with chronic infection should use extreme caution. TB, invasive fungal, and other opportunistic infections have been observed in patients taking this drug and some infections have been fatal; most infections occur in combination with other immunosuppressants. Lymphomas and other malignancies (cancers), some fatal, have been reported in children and adolescents treated with drugs like Humira.
ENTOCORT (BUDESONIDE)
- Total adverse event reports: 703
- Average age: 49 years
- Reported Deaths: ?
- Male: 33%
- Female: 62%
- Gender Unknown: 5%
- Headache
- Respiratory tract infection
- Gastrointestinal upset
- Dizziness
- Fatigue
- Excessive hair growth
- Weight gain
- Moon face
- Swollen ankles
- Pain
Most common adverse effects reported to FDA:
- Stomach upset (Including diarrhea, nausea)
- Weight loss
- Dizziness
- Malaise
- Drug ineffectiveness
- Cataracts
- Fatigue
You should avoid this drug if:
- Budesonide should only be used in pregnant women if necessary and if potential benefits outweigh the unknown risk.
- Use of budesonide during pregnancy may suppress the adrenal glands of the infant.
- Avoid anyone who an infection such as chickenpox or measles
- Grapefruit juice can increase the amount of Entocort EC in your blood stream; do not drink grapefruit juice while taking this drug
Used for the for the treatment of mild to moderate active Crohn’s disease
Use of this drug results in immunosuppression, therefore existing infections (tuberculosis, bacterial, viral, parasitic, or fungal) may clearly worsen. More serious or fatal chickenpox or measles may occur in susceptible patients. Lymphoma and other cancers have been reported on rare occasions.
LUNESTA (ESZOPICLONE)
- Total adverse event reports: 10,512
- Average age: 58 years
- Reported Deaths: ?
- Male: 33%
- Female: 61%
- Gender Unknown: 6%
- Temporary amnesia (some people using this medicine have engaged in activity such as driving, eating, or making phone calls and later having no memory of the activity)
- Impaired thinking or reactions
- Headache
- Dizziness
- Drowsiness
- Dry mouth
- Feeling sleepy the next day
Most common adverse effects reported to FDA:
- Drug ineffectiveness
- Insomnia (both initial and middle of the night)
- Sleepiness
- Headache
- Nausea
- Dizziness
- Decreased effectiveness with use
You should avoid this drug if:
- You are pregnant or breastfeeding. Ambien can be found in breast milk if taken while breastfeeding. Tell your healthcare provider immediately if you are pregnant, plan to become pregnant, or are breastfeeding.
Used to treat insomnia
Avoid alcohol when taking this drug. The above side effects may worsen if you take Lunesta with alcohol. Do not drive or engage in activities that require complete alertness after taking Lunesta.
OXYCONTIN (OXYCODONE)
- Total adverse event reports: 1,648
- Average age: 46 years
- Reported Deaths: 125
- Male: 38%
- Female: 46%
- Gender Unknown: 16%
- Constipation
- Nausea
- Drowsiness
- Fatigue
- Addiction (habit forming, even at regular doses)
Most common adverse effects reported to FDA:
You should avoid this drug if:
- Completed suicide
- Cardiac and respiratory arrest
- Drug ineffectiveness
- Death
- Drug toxicity
- Drug misuse/abuse
- Sleepiness
Used to treat moderate to severe pain that is expected to last for an extended period of time. OxyContin is used for around-the-clock treatment of pain. It is not to be used on an “as-needed” basis for pain.
Because of its high potential for addiction and abuse, this drug should be used with extreme caution. After using for extended periods of time you must gradually reduce dosage in order to avoid risk of respiratory depression and other effects of withdrawal. Ingestion by children may lead to fatal overdose. Prolonged use during pregnancy can also lead to life-threatening withdrawal in newborns. This drug will be present in breast milk.
NEXIUM (ESOMEPRAZOLE MAGNESIUM)
- Total adverse event reports: 34,845
- Average age: 60 years
- Reported Deaths: 357
- Male: 29%
- Female: 66%
- Gender Unknown: 5%
- Headache
- Diarrhea
- Abdominal pain
- Nausea
- Drowsiness
Most common adverse effects reported to FDA:
- Gastrointestinal reflux
- Abdominal pain and upset (nausea, vomiting, discomfort)
- Malaise
- Drug ineffectiveness
- Osteoporosis
- Pain
You should avoid this drug if:
- Do not breastfeed while you are taking Nexium.
- Tell your healthcare provider immediately if you are pregnant, plan to become pregnant, or are breastfeeding.
Used to treat epilepsy, diabetic peripheral neuropathy, fibromyalgia, post-herpetic neuralgia, shingles, neuropathic pain associated with spinal cord injury, and certain types of seizures.
The FDA is being asked to issue black box warnings regarding the long-term use of PPI drugs such as Nexium, Prevacid, Prilosec, and other acid reflux inhibitors. These drugs have been associated with a variety of potentially serious side effects, including an increased risk of bone fractures (especially in the elderly). Other side effects may include infections, diarrhea, and magnesium deficiency leading to heart problems.
LYRICA (PREGABALIN)
- Total adverse event reports: 44,200
- Average age: 59 years
- Reported Deaths: 703
- Male: 27%
- Female: 60%
- Gender Unknown: 13%
- Dizziness
- Drowsiness
- Problems with memory
- Concentration
- Dry mouth
- Constipation
- Difficulty concentrating
- Swollen arms/legs
- Weight gain
- Fatigue
- Nausea
- Elevated mood
- Headache
- Lack of coordination and balance
- Muscle twitching
- Increased appetite
- Back pain
- Swelling of the hands, feet, arms, ankles, or lower legs
- Serious side effects of taking Lyrica may include: blurred vision, hives, rash, itching, blisters, swelling of the face, throat, mouth, gums, tongue, lips, neck or head, muscle pain, chest pain, shortness of breath and wheezing
Most common adverse effects reported to FDA:
- Dizziness
- Weight gain
- Drug ineffectiveness
- Pain
- Sleepiness
- Peripheral edema
- Blurred vision
- Fatigue
- Nausea
You should avoid this drug if:
- Lyrica is an FDA pregnancy category C drug. It is not known whether pregabalin will harm an unborn baby, or exactly how it will affect your baby while breastfeeding. You should not breast-feed while you are using pregabalin.
- Tell your doctor if you have kidney disease, bleeding disorder, or history of depression
Used to treat epilepsy, diabetic peripheral neuropathy, fibromyalgia, post-herpetic neuralgia, shingles, neuropathic pain associated with spinal cord injury, and certain types of seizures.
Suicidal behavior and Ideation – Antiepileptic drugs (AEDs), including Lyrica, increase the risk of suicidal thoughts or behavior in patients taking these drugs for any indication. Patients treated with any AED should be monitored for the emergence or worsening of depression, suicidal thoughts or behavior, and/or any unusual changes in mood or behavior….Usage in pregnancy should also be done with caution. In order to provide information regarding the effects of in utero exposure to Lyrica, physicians are advised to recommend that pregnant patients taking Lyrica enroll in the North American Antiepileptic Drug (NAAED) Pregnancy Registry.
SPIRIVA (TIOTROPIUM BROMIDE)
- Total adverse event reports: 32,891
- Average age: 68 years
- Reported Deaths: 527
- Male: 35%
- Female: 55%
- Gender Unknown: 10%
- Dry mouth
- Constipation
- Rapid heartbeat
- Blurred vision
- Glaucoma (new onset or worsening)
- Painful urination
- Urinary retention
Most common adverse effects reported to FDA:
- Difficulty breathing, speaking
- Cough
- Pneumonia
- Blurred vision
- Constipation, dry mouth
- Dizziness
You should avoid this drug if:
- Tell your doctor immediately if you are pregnant, plan to become pregnant, or are breastfeeding. The effects of Spiriva HandiHaler during pregnancy and breastfeeding are unknown.
Used for the long-term maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), chronic bronchitis, and emphysema.
At one time, the FDA issued warnings (not black box) that Spiriva could pose some serious side effects to patients using this drug. While some patients have reported possible side effects such as increased risk of stroke, cardiovascular events, and macular degeneration, the FDA (as of January 2010) does not support the association.
VIAGRA (SILDENAFIL)
- Total adverse event reports: 12.472
- Average age: 57 years
- Reported Deaths: 247
- Male: 91%
- Female: 2%
- Gender Unknown: 7%
- Dizziness
- Headache
- Upset stomach
- Vision changes including increased sensitivity to light, blurred vision, and trouble telling blue and green colors apart may also occur.
Most common adverse effects reported to FDA:
- Drug ineffectiveness
- Headache
- Erectile dysfunction
- Optic nerve function loss (as well as blindness, blurred vision)
- Penile disorder
- Dizziness
You should avoid this drug if:
- You have been instructed by your doctor not to engage in sexual activity due to heart disease or other heart problems
- You are taking medicines that contain nitrates of any kind. If you take Viagra with any nitrate medicine your blood pressure could suddenly drop to an unsafe or life-threatening level.
Viagra is used to treat erectile dysfunction (impotence) in men. Another brand of sildenafil is Revatio, which is used to treat pulmonary arterial hypertension and improve exercise capacity in men and women.
Rarely, sudden decreased vision in one or both eyes may occur. Sudden decrease or loss of hearing, sometimes with dizziness and ringing in the ears, may also occur. In the rare event you have a painful or prolonged erection lasting 4 or more hours, stop using this drug and get medical help right away, or permanent problems could occur.
VICODIN (HYDROCODONE/ACETAMINOPHEN)
- Total adverse event reports: 11,224
- Average age: 46 years
- Reported Deaths: 59
- Male: 34%
- Female: 49%
- Gender Unknown: 17%
- Sedation
- Constipation
- Nausea
- Upset stomach
- Death in high doses
Most common adverse effects reported to FDA:
- Completed suicide
- Cardiac and respiratory arrest
- Drug misuse/abuse
- Drug ineffectiveness
- Nausea (stomach upset, vomiting)
You should avoid this drug if:
- You are allergic to codeine
Used to treat moderate to severe pain. Also used to prevent cough.
Can become habit-forming when used over an extended period of time. It is important not to mix with anything containing alcohol or acetaminophen, as this could lead to liver toxicity. This drug can be lethal in high doses.
XANAX (ALPRAZOLAM)
- Total adverse event reports: 6,361
- Average age: 49 years
- Reported Deaths: 97
- Male: 35%
- Female: 59%
- Gender Unknown: 6%
- Drowsiness
- Lightheadedness
- Confusion
- Depression
- Memory loss
- Slurred speech
- Lethargy
Most common adverse effects reported to FDA:
- Anxiety
- Drug ineffectiveness and insomnia
- Depression
- Sleepiness
- Headache
- Suicidality
- Panic attacks
- Nausea
- Malaise (general feeling of discomfort, disease, ill feeling)
You should avoid this drug if:
- Do not breastfeed while you are taking Xanax. This drug is found in breast milk if taken while breastfeeding
- Xanax can harm your unborn baby if you take it during pregnancy. Tell your healthcare provider immediately if you are pregnant, plan to become pregnant
- Do not drink alcohol while you are taking Xanax
- Do not drive a car, operate machinery, or engage in other dangerous activities until you know how this drug affects you
- Do not drink grapefruit juice without first consulting your physician
Used for the management of anxiety disorder, short-term relief of anxiety symptoms, and treatment of panic disorder.
Xanax is a federally controlled substance because it has high abuse potential. Seizures can occur if you stop or decrease your dose suddenly.
XELJANZ (TOFACITINIB CITRATE)
- Total adverse event reports: 3,385
- Average age: 71 years
- Reported Deaths: 101
- Male: 37%
- Female: 45%
- Gender Unknown: 18%
- Hepatitis B or C activation
- Upper respiratory tract infections (common cold, sinus infections)
- Headache
- Diarrhea
- Cancer and immune system problems
Most common adverse effects reported to FDA:
- N/A
You should avoid this drug if:
- You are pregnant or plan to become pregnant. It is not known if or how Xeljanz will harm an unborn baby. Pregnancy Registry: Pfizer has a registry for pregnant women who take this drug. These registries track the health of the pregnant mother and her baby. For now, it is not known exactly how this drug may affect your baby.
- Do not breastfeed while on this drug.
- Do not receive live vaccines while on this drug.
Used to treat adults with moderately to severely active rheumatoid arthritis when methotrexate did not work well. (A folate analog metabolic inhibitor, or cell division inhibitor, is used to treat several kinds of cancer, rheumatoid arthritis, and psoriasis.)
Taking Xeljanz can lower the ability of your immune system to fight infections. Some people have serious infections while taking this drug, including tuberculosis (TB), and infections caused by bacteria, fungi, or viruses that can spread throughout the body. Some people have died from these infections.
XARELTO (RIVAROXABAN)
- Total adverse event reports: 3,385
- Average age: 71 years
- Reported Deaths: 101
- Male: 37%
- Female: 45%
- Gender Unknown: 18%
- Muscle pain
- Itching
- Pain in extremities
- Bruising
- Uncontrolled bleeding: Uncontrolled bleeding is one of the most severe side effects of Xarelto. When bleeding occurs near a major organ (the brain, lungs, or kidneys) blood flow to that organ is interrupted, causing it to lose some or all of its functionality.
- Because this drug prevents the blood from clotting, hemorrhaging will continue until the drug is flushed out of the system.
Most common adverse effects reported to FDA:
- Pulmonary embolism
- Deep vein thrombosis
- Gastrointestinal hemorrhage
- Bleeding (Including vascular and intracranial hemorrhage)
- Blood clot
- Stroke
- Anemia
- Skin conditions (rash, eruptions, discoloration, etc.)
You should avoid this drug if:
- You are planning to undergo any type of spinal tap or spinal surgery in the near future. Xarelto can also cause serious blood clot around the spinal cord if the patient undergoes a spinal tap or receives an epidural, if there is a history of spinal surgery or repeated spinal taps, or if other drugs that can affect blood clotting are being used concurrently. This type of blood clot can lead to long-term or permanent paralysis.
Used to prevent or treat a type of blood clot which can lead to blood clots in the lungs (pulmonary embolism)
Use extreme caution with discontinuation of drug treatment as the risk of stroke is increased. There is also higher risk of hematoma (blood clot) after spinal puncture (epidural or other spinal anesthesia). The risk of permanent paralysis increases with the use of epidural catheter and certain drugs (NSAIDs, other anticoagulants), spinal deformity, spinal puncture, or spinal surgery.